CLINICAL_TRIALS
trial_result
· 2017-09-12
Clinical Trial Update: Investigation of Naltrexone for Pathological Gambling [Phase 2]
Summary
Phase 2 trial of naltrexone for gambling disorder has completed and results were posted in 2017. The study was sponsored by Yale University.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Pathological Gambling | Phase 2 | Status: COMPLETED | Results posted: 2017-09-12